2022 Q1 Form 10-Q Financial Statement
#000149315222013927 Filed on May 16, 2022
Income Statement
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| Revenue | ||
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $1.492M | $1.510M |
| YoY Change | -1.18% | 42.45% |
| % of Gross Profit | ||
| Research & Development | $2.630M | -$20.00K |
| YoY Change | -13248.7% | -100.81% |
| % of Gross Profit | ||
| Depreciation & Amortization | $0.00 | |
| YoY Change | -100.0% | |
| % of Gross Profit | ||
| Operating Expenses | $4.122M | $1.490M |
| YoY Change | 176.63% | -57.91% |
| Operating Profit | -$4.122M | -$1.490M |
| YoY Change | 176.63% | -57.91% |
| Interest Expense | -$4.620K | $30.00K |
| YoY Change | -115.4% | -40.0% |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$180.00 | |
| YoY Change | ||
| Pretax Income | -$4.122M | -$1.450M |
| YoY Change | 184.28% | -58.92% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$4.122M | -$3.090M |
| YoY Change | 33.41% | -12.72% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | -$0.11 | |
| Diluted Earnings Per Share | -$108.1K | -$173.3K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 38.12M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $9.188M | $31.05M |
| YoY Change | -70.41% | 317.34% |
| Cash & Equivalents | $1.189M | |
| Short-Term Investments | $7.999M | $30.48M |
| Other Short-Term Assets | $884.1K | $220.0K |
| YoY Change | 301.87% | -35.29% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $10.07M | $34.30M |
| YoY Change | -70.63% | 313.25% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $132.8K | |
| YoY Change | ||
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $1.500M | |
| YoY Change | ||
| Other Assets | $1.500M | |
| YoY Change | 305.41% | |
| Total Long-Term Assets | $12.13M | $1.500M |
| YoY Change | 708.75% | 82.93% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $10.07M | $34.30M |
| Total Long-Term Assets | $12.13M | $1.500M |
| Total Assets | $22.20M | $35.80M |
| YoY Change | -37.98% | 292.54% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.996M | $2.340M |
| YoY Change | -14.7% | 15.27% |
| Accrued Expenses | $470.7K | |
| YoY Change | ||
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $2.467M | $2.370M |
| YoY Change | 4.08% | 8.72% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $114.6K | |
| YoY Change | ||
| Total Long-Term Liabilities | $114.6K | $0.00 |
| YoY Change | -100.0% | |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $2.467M | $2.370M |
| Total Long-Term Liabilities | $114.6K | $0.00 |
| Total Liabilities | $2.581M | $2.370M |
| YoY Change | 8.92% | 3.04% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $19.62M | -$8.347M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $22.20M | $35.80M |
| YoY Change | -37.98% | 292.54% |
Cashflow Statement
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$4.122M | -$3.090M |
| YoY Change | 33.41% | -12.72% |
| Depreciation, Depletion And Amortization | $0.00 | |
| YoY Change | -100.0% | |
| Cash From Operating Activities | -$2.366M | -$2.480M |
| YoY Change | -4.59% | 25.89% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | ||
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $2.999M | -$15.57M |
| YoY Change | -119.26% | -788.94% |
| Cash From Investing Activities | $2.999M | |
| YoY Change | ||
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 0.000 | |
| YoY Change | ||
| NET CHANGE | ||
| Cash From Operating Activities | -2.366M | -2.480M |
| Cash From Investing Activities | 2.999M | |
| Cash From Financing Activities | 0.000 | |
| Net Change In Cash | $0.00 | $0.00 |
| YoY Change | -100.0% | |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$2.366M | -$2.480M |
| Capital Expenditures | ||
| Free Cash Flow | ||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q1 | MYMD |
Gain Loss On Sale Of Equity Investment
GainLossOnSaleOfEquityInvestment
|
USD | |
| CY2022Q1 | MYMD |
Proceeds From Borrowings
ProceedsFromBorrowings
|
USD | |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
USD | |
| CY2021Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
USD | |
| CY2021Q1 | MYMD |
Gain Loss On Uninsured Casualty
GainLossOnUninsuredCasualty
|
USD | |
| CY2021Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
USD | |
| CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2022Q1 | MYMD |
Exercise Of Prepaid Equity Forward Contracts For Common Stock
ExerciseOfPrepaidEquityForwardContractsForCommonStock
|
USD | |
| CY2022Q1 | MYMD |
Accrued Interestdividends
AccruedInterestdividends
|
USD | |
| CY2022Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
USD | |
| CY2021Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
USD | |
| CY2021Q1 | MYMD |
Gain Loss On Sale Of Equity Investment
GainLossOnSaleOfEquityInvestment
|
USD | |
| CY2021Q1 | us-gaap |
Restricted Stock Expense
RestrictedStockExpense
|
USD | |
| CY2021Q1 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
USD | |
| CY2021Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
USD | |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | |
| CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
USD | |
| CY2021Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
USD | |
| CY2022Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
USD | |
| CY2021Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
USD | |
| CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
USD | |
| CY2021Q1 | us-gaap |
Gross Profit
GrossProfit
|
USD | |
| CY2022Q1 | MYMD |
Interest Expense Accretion Of Debt Discount
InterestExpenseAccretionOfDebtDiscount
|
USD | |
| CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
USD | |
| CY2021Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
USD | |
| CY2022Q1 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
USD | |
| CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
| CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
USD | |
| CY2022Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
| CY2021Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
| CY2022Q1 | MYMD |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
|
USD | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
| CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
|
||
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
shares | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
||
| CY2022Q1 | MYMD |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Expired In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrExpiredInPeriodWeightedAverageGrantDateFairValue
|
